Equity, technology, and costs top of mind for life science's leaders

Physicians, researchers, CEOs, reporters, and more gathered in downtown Boston Wednesday night to celebrate STAT’s 2024 STATUS List, which features 50 leaders in the life sciences. Members of this year’s list (and a few past list members) spoke about what issues in their fields — ranging from investment to clinical research to bedside treatment — need to be prioritized in order to improve health care across the U.S. and the rest of the world.

Equity and inclusion

Achieving true equity in medical science “requires us to divest our research from the ivory towers of elite institutions,” said 2023 list member Jonathan Jackson, executive director of Community Access, Recruitment, and Engagement Research Center at Massachusetts General Hospital and Harvard Medical School. Too often, he said, researchers and advocates bring “the same solutions to the same institutions” who don’t prioritize the needs of marginalized populations.

Read the rest…